News

Company had a strong start to 2025, emerging as an R&D-focused organization Exclusive license agreement with ...
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update Phase 2b Trial of Halneuron® in CINP underway; Interim Results ...